“Reconnecting the Dots — Reinterpreting Industry–Physician…
Lisa Rosenbaum, MD recently published an article entitled “Reconnecting the Dots—Reinterpreting Industry-Physician Relations,” in…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
May 2015
New York Introduces Pharmaceutical Cost Transparency Bill
New York is the latest state to introduce a “pharmaceutical cost transparency act,” following five others—California,…
Open Payments Analytics Offers Companies “Competitive…
The Open Payments database lists most transfers of value made by pharmaceutical and device manufacturers to physicians and…
Biosimilars 20/20 Conference: June 3-4 in Philadelphia, PA
Biosimilars 20/20 will take place from June 3 – 4 in Philadelphia, PA. The two-day conference is presented by the…
Update on the Medical Device Tax Repeal Efforts
The Medical Device Tax, instituted as part of the Affordable Care Act, is a tax of 2.3 percent on the sale price of medical device…
District Court Dismisses Chicago’s Painkiller Marketing Lawsuit…
District Court Judge Jorge Alonso of the Northern District of Illinois recently dismissed the City of Chicago’s lawsuit…
ExL Pharma 6th Aggregate Spend and Sunshine Act Conference
ExL Pharma's 6th Aggregate Spend and Sunshine Act Conference will take place on June 8-9 in Philadelphia, PA. The…
Update on French Sunshine Law
The Sunshine Act in the United States is but one physician payment disclosure obligation for manufacturers of drugs and…
Amarin v. FDA and Public Meeting On Off-Label Promotion Signal An Important…
2015 could prove to be a significant year for how the Food and Drug Administration approaches drug companies’ off-label speech.…
Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical…
Long a champion of physician and industry collaboration, Thomas Stossel, M.D., has published a new book entitled …